Ilan Rozenberg, Sydney Benchetrit, Tali Zitman-Gal, Moanis Ajaj, Maysam Shehab, Naomi Nacasch, Keren Cohen-Hagai
{"title":"隧道式透析导管功能障碍的发生率和预测因素。","authors":"Ilan Rozenberg, Sydney Benchetrit, Tali Zitman-Gal, Moanis Ajaj, Maysam Shehab, Naomi Nacasch, Keren Cohen-Hagai","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hemodialysis requires reliable, recurrent access to the circulatory system. Central venous tunneled dialysis catheters (TDC) are frequently used for patients receiving hemodialysis as a bridge to permanent vascular access or as a final option. TDC are prone to complications such as infection and dysfunction.</p><p><strong>Objectives: </strong>To assess the prevalence and predictors of TDC dysfunction in a cohort of chronic hemodialysis patients.</p><p><strong>Methods: </strong>This single-center, retrospective study was based on data from an electronic database of chronic hemodialysis patients during 5 years of follow-up.</p><p><strong>Results: </strong>A total of 625 TDC were inserted in 361 patients, of which 234 (37.4%) were replaced due to dysfunction. The main insertion site was the right internal jugular vein. Diabetes mellitus was an important predictor of TDC dysfunction and was significantly correlated with TDC extraction. Chronic anticoagulation and antiplatelet treatment did not affect the rate of TDC dysfunction or replacement.</p><p><strong>Conclusions: </strong>TDC use for chronic dialysis patients is increasing and dysfunction is a major problem. In our study, we highlighted the high prevalence of TDC dysfunction and the need for further research to improve hemodialysis access as well as TDC patency and function.</p>","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 8","pages":"508-513"},"PeriodicalIF":1.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence and Predictors of Tunneled Dialysis Catheter Dysfunction.\",\"authors\":\"Ilan Rozenberg, Sydney Benchetrit, Tali Zitman-Gal, Moanis Ajaj, Maysam Shehab, Naomi Nacasch, Keren Cohen-Hagai\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Hemodialysis requires reliable, recurrent access to the circulatory system. Central venous tunneled dialysis catheters (TDC) are frequently used for patients receiving hemodialysis as a bridge to permanent vascular access or as a final option. TDC are prone to complications such as infection and dysfunction.</p><p><strong>Objectives: </strong>To assess the prevalence and predictors of TDC dysfunction in a cohort of chronic hemodialysis patients.</p><p><strong>Methods: </strong>This single-center, retrospective study was based on data from an electronic database of chronic hemodialysis patients during 5 years of follow-up.</p><p><strong>Results: </strong>A total of 625 TDC were inserted in 361 patients, of which 234 (37.4%) were replaced due to dysfunction. The main insertion site was the right internal jugular vein. Diabetes mellitus was an important predictor of TDC dysfunction and was significantly correlated with TDC extraction. Chronic anticoagulation and antiplatelet treatment did not affect the rate of TDC dysfunction or replacement.</p><p><strong>Conclusions: </strong>TDC use for chronic dialysis patients is increasing and dysfunction is a major problem. In our study, we highlighted the high prevalence of TDC dysfunction and the need for further research to improve hemodialysis access as well as TDC patency and function.</p>\",\"PeriodicalId\":50268,\"journal\":{\"name\":\"Israel Medical Association Journal\",\"volume\":\"26 8\",\"pages\":\"508-513\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Israel Medical Association Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Israel Medical Association Journal","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Prevalence and Predictors of Tunneled Dialysis Catheter Dysfunction.
Background: Hemodialysis requires reliable, recurrent access to the circulatory system. Central venous tunneled dialysis catheters (TDC) are frequently used for patients receiving hemodialysis as a bridge to permanent vascular access or as a final option. TDC are prone to complications such as infection and dysfunction.
Objectives: To assess the prevalence and predictors of TDC dysfunction in a cohort of chronic hemodialysis patients.
Methods: This single-center, retrospective study was based on data from an electronic database of chronic hemodialysis patients during 5 years of follow-up.
Results: A total of 625 TDC were inserted in 361 patients, of which 234 (37.4%) were replaced due to dysfunction. The main insertion site was the right internal jugular vein. Diabetes mellitus was an important predictor of TDC dysfunction and was significantly correlated with TDC extraction. Chronic anticoagulation and antiplatelet treatment did not affect the rate of TDC dysfunction or replacement.
Conclusions: TDC use for chronic dialysis patients is increasing and dysfunction is a major problem. In our study, we highlighted the high prevalence of TDC dysfunction and the need for further research to improve hemodialysis access as well as TDC patency and function.
期刊介绍:
The Israel Medical Association Journal (IMAJ), representing medical sciences and medicine in Israel, is published in English by the Israel Medical Association.
The Israel Medical Association Journal (IMAJ) was initiated in 1999.